Law360, New York ( December 8, 2011, 1:07 PM EST) -- On Nov. 3, GlaxoSmithKline PLC announced that it will pay $3 billion to settle civil and criminal allegations that it promoted the drug Avandia for off-label uses.[1] This is only the latest in a long list of such settlements. Since 2004, pharmaceutical companies have paid a combined $13 billion to settle charges of off-label promotion of numerous brand-name drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.